Liang Shan

Anhui Province Key Laboratory Of Major Autoimmune Diseases
Hefei, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Caffeine improves diethylnitrosamine-induced hepatocellular carcinoma by inhibiting cAMP/PKA/CREB signaling in rats.

Caffeine improves diethylnitrosamine-induced hepatocellular carcinoma by inhibiting cAMP/PKA/CREB signaling in rats.

Journal: Biochemistry and biophysics reports

Published: March 24, 2025

Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.

Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 17, 2025

Caveolin-1 protects against liver injury and lipid accumulation in alcoholic fatty liver via ferroptosis resistance.

Caveolin-1 protects against liver injury and lipid accumulation in alcoholic fatty liver via ferroptosis resistance.

Journal: Molecular immunology

Published: March 03, 2024

Kasai Portoenterostomy, Successful Liver Transplantation, and Immunosuppressive Therapy for Biliary Atresia in a Female Baby: A Case Report.

Kasai Portoenterostomy, Successful Liver Transplantation, and Immunosuppressive Therapy for Biliary Atresia in a Female Baby: A Case Report.

Journal: Journal of inflammation research

Published: August 23, 2023

Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.

Caffeine in Hepatocellular Carcinoma: Cellular Assays, Animal Experiments, and Epidemiological Investigation.

Journal: Journal of inflammation research

Published: June 05, 2023

Corrigendum to: "Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis", [Biomed. Pharmacother., 161; (2023): 114472].

Corrigendum to: "Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis", [Biomed. Pharmacother., 161; (2023): 114472].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 02, 2023

New insights into fibrotic signaling in hepatocellular carcinoma.

New insights into fibrotic signaling in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: March 29, 2023

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 27, 2022

Caffeine in liver diseases: Pharmacology and toxicology.

Caffeine in liver diseases: Pharmacology and toxicology.

Journal: Frontiers in pharmacology

Published: August 28, 2022

Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.

Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.

Journal: PeerJ

Published: July 28, 2022

New Drugs for Hepatic Fibrosis.

New Drugs for Hepatic Fibrosis.

Journal: Frontiers in pharmacology

Published: February 12, 2022

Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease.

Purine signaling regulating HSCs inflammatory cytokines secretion, activation, and proliferation plays a critical role in alcoholic liver disease.

Journal: Molecular and cellular biochemistry

Published: August 13, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026